406 related articles for article (PubMed ID: 31483578)
21. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
Ward EM; Fedewa SA; Cokkinides V; Virgo K
Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
[TBL] [Abstract][Full Text] [Related]
22. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Am J Hematol; 2016 May; 91(5):476-80. PubMed ID: 26852276
[TBL] [Abstract][Full Text] [Related]
23. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
24. The impact of health insurance status on the survival of patients with head and neck cancer.
Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
[TBL] [Abstract][Full Text] [Related]
25. Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Shin JY; Yoon JK; Diaz AZ
J Neurooncol; 2017 Mar; 132(1):89-98. PubMed ID: 27864706
[TBL] [Abstract][Full Text] [Related]
26. Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis.
Diessner BJ; Weigel BJ; Murugan P; Zhang L; Poynter JN; Spector LG
JAMA Netw Open; 2020 Aug; 3(8):e2011087. PubMed ID: 32766799
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
Movva S; von Mehren M; Ross EA; Handorf E
J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
[TBL] [Abstract][Full Text] [Related]
28. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
29. Insurance Status Effect on Laryngeal Cancer Survival: A Population Based Study.
Abt NB; Miller LE; Parikh A; Bhattacharyya N
Ann Otol Rhinol Laryngol; 2022 Jul; 131(7):775-781. PubMed ID: 34486418
[TBL] [Abstract][Full Text] [Related]
30. Treatment Approaches and Outcomes for Primary Mediastinal Sarcoma: Analysis of 976 Patients.
Engelhardt KE; DeCamp MM; Yang AD; Bilimoria KY; Odell DD
Ann Thorac Surg; 2018 Aug; 106(2):333-339. PubMed ID: 29729268
[TBL] [Abstract][Full Text] [Related]
31. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
32. Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer.
Stokes SM; Wakeam E; Swords DS; Stringham JR; Varghese TK
Surgery; 2018 Dec; 164(6):1287-1293. PubMed ID: 30170821
[TBL] [Abstract][Full Text] [Related]
33. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
Fedewa SA; Lerro C; Chase D; Ward EM
Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
[TBL] [Abstract][Full Text] [Related]
34. Impact of Insurance Status on Stage, Treatment, and Survival in Patients with Colorectal Cancer: A Population-Based Analysis.
Sun W; Cheng M; Zhuang S; Qiu Z
Med Sci Monit; 2019 Apr; 25():2397-2418. PubMed ID: 30939127
[TBL] [Abstract][Full Text] [Related]
35. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
[TBL] [Abstract][Full Text] [Related]
36. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
[TBL] [Abstract][Full Text] [Related]
37. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
38. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
Cabo J; Shu X; Shu XO; Parikh A; Bailey C
J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
[TBL] [Abstract][Full Text] [Related]
39. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
40. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]